GlassScriptPhysician profile
Christopher J Esposito
NPI 1528416989
$7,646.04
in general payments reported to CMS, 2019-2025
8 companies · $123 in 2025
The $123 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $436 · 2022: $1,251 · 2023: $3,192 · 2024: $2,644 · 2025: $123.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,000 · Travel and Lodging: $1,292 · Food and Beverage: $668.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,000.00 |
| Travel and Lodging | $1,291.59 |
| Food and Beverage | $667.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,246.69 | 2021-2025 | Da Vinci Surgical System, Davinci Xi |
| Medical Device Business Services, INC. | $1,749.06 | 2022-2024 | Linx Reflux Management System |
| Ethicon US, LLC | $1,010.79 | 2021-2024 | Linx Reflux Management System, Echelon; Endopath |
| Medtronic, INC. | $428.12 | 2021-2022 | |
| Davol INC. | $93.37 | 2022 | |
| Boston Scientific Corporation | $53.40 | 2022 | |
| W. L. Gore & Associates, INC. | $45.29 | 2021 | |
| Baudax Bio INC. | $19.32 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Esposito listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.